Yingjia Li Selected Research

Yingjia Li Research Topics

Disease

18	Neoplasms (Cancer) 03/2024 - 03/2002
4	Breast Neoplasms (Breast Cancer) 04/2020 - 03/2002
3	Inflammation (Inflammations) 01/2023 - 10/2020
3	Hypoxia (Hypoxemia) 01/2022 - 02/2020
2	Hyperthermia 09/2023 - 02/2020
2	Rheumatoid Arthritis 01/2023 - 10/2021
2	Hemophilia A (Haemophilia) 01/2023 - 01/2023
1	Hepatitis 06/2023
1	Hematoma 01/2023
1	Joint Diseases (Joint Disease) 01/2023
1	Carcinogenesis 12/2022
1	Colonic Neoplasms (Colon Cancer) 12/2022
1	Triple Negative Breast Neoplasms 09/2022
1	Bacterial Infections (Bacterial Infection) 08/2022
1	Arthritis (Polyarthritis) 10/2021
1	Experimental Arthritis 10/2021
1	Infections 01/2021
1	Peritonitis 01/2021
1	Fibrosis (Cirrhosis) 11/2020
1	Heart Failure 11/2020
1	Hepatocellular Carcinoma (Hepatoma) 06/2020
1	Neoplasm Metastasis (Metastasis) 06/2020
1	Liver Neoplasms (Liver Cancer) 06/2020
1	Ischemia 01/2019
1	Stomach Neoplasms (Stomach Cancer) 06/2018
1	Glioma (Gliomas) 01/2018
1	Body Weight (Weight, Body) 01/2017
1	Osteosarcoma (Osteogenic Sarcoma) 03/2002
1	Lymphatic Metastasis 03/2002

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2017
3	Oxygen (Dioxygen)IBA 08/2022 - 02/2020
3	Proteins (Proteins, Gene)FDA Link 06/2020 - 03/2002
2	AntioxidantsIBA 01/2024 - 01/2022
2	CytokinesIBA 01/2023 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2022
2	CatalaseIBA 08/2022 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2022 - 02/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 10/2020 - 06/2020
2	MicroRNAs (MicroRNA)IBA 06/2020 - 06/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 01/2017
1	EnzymesIBA 03/2024
1	AcidsIBA 01/2024
1	Therapeutic UsesIBA 09/2023
1	Antiviral Agents (Antivirals)IBA 06/2023
1	SimeprevirIBA 06/2023
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2023
1	IonsIBA 01/2023
1	SilverIBA 01/2023
1	Sincalide FDA Link 12/2022
1	ChromatinIBA 12/2022
1	Transcription Factors (Transcription Factor)IBA 12/2022
1	Circular RNAIBA 12/2022
1	Photosensitizing Agents (Photosensitizers)IBA 08/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	MagnesiumIBA 10/2021
1	HydrogenIBA 10/2021
1	Metal-Organic FrameworksIBA 10/2021
1	Hyaluronic Acid (Hyaluronan)IBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2020
1	InflammasomesIBA 11/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2020
1	CateninsIBA 11/2020
1	Autophagy-Related ProteinsIBA 06/2020
1	VimentinIBA 06/2020
1	Cadherins (E-Cadherin)IBA 06/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2020
1	GoldIBA 02/2020
1	ElementsIBA 02/2020
1	Superoxide DismutaseIBA 01/2019
1	Polysorbates (PSML)FDA Link 01/2018
1	ProdrugsIBA 01/2017
1	LigandsIBA 01/2017
1	5,8- dihydroxy- 2- (2- (4- methoxyphenyl)ethyl)chromoneIBA 01/2017
1	Cell-Penetrating PeptidesIBA 01/2017
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2016
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2002
1	Monoclonal AntibodiesIBA 03/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2002

Therapy/Procedure

9	Therapeutics 09/2023 - 03/2002
4	Radiotherapy 09/2022 - 02/2020
3	Lasers (Laser) 09/2023 - 02/2020
2	Photochemotherapy (Photodynamic Therapy) 08/2022 - 02/2020
2	Drug Therapy (Chemotherapy) 04/2020 - 01/2019
2	Microbubbles 01/2019 - 01/2017
1	Photothermal Therapy 09/2023
1	Radioimmunotherapy 01/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2023
1	Transplantation 12/2022
1	Chemoradiotherapy 01/2022
1	Precision Medicine 02/2020
1	Nanospheres 02/2020